received this info from email...
*PASS THIS ON EVEN IF YOU DO NOT USE IT*
Recently this past week, Nicole Dishuk (age 31...newly graduated student with a doctoral degree about to start her new career as a Doctor....) was flown into a nearby hospital, because she passed out.
They found a blood clot in her neck, and immediately took her by helicopter to the ER to operate. By the time they removed the right half of her skull to relieve the pressure on her brain; the clot had spread to her brain causing severe damage.
Since last Wednesday night, she was battling... they induced her into a coma to stop the blood flow, they operated 3 times... Finally, they said there was nothing left that they could do... they found multiple clots in the left side of her brain... the swelling wouldn't stop, and she was on life
support...
She died at 4:30 yesterday. She leaves behind a husband, a 2yr old Brandon and a 4yr old Justin... The CAUSE of DEATH - they found was a birth control she was taking that allows you to only have your period 3 times a year... They said it interrupts life's menstrual cycle, and although it is FDA approved... shouldn't be - So to the women in my address book - I ask you to
boycott this product & deal with your period once a month - so you can live the rest of the months that your life has in store for you.
*Please send this to every woman you know - you may save someone's life... *Remember, you have a CYCLE for a reason*!
The name of this new birth control pill is *LYBREL** *. If you go to http://lybrel.com/, you will find at least 26 pages of information regarding this drug.
The second birth control pill is, *SEASONIQUE* . If you go to the website http://seasonique.com/, you will find 43 pages of information regarding this drug.
The warnings and side effects regarding both pills are horrible. Please, please forward this information to as many daughters AND sons, co-workers, friends and relatives. Several lives have already been changed.
Sunday, November 22, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment